Effect of spironolactone on vascular stiffness in hemodialysis patients: a randomized crossover trial

BACKGROUND: The role of spironolactone treatment in hemodialysis patients is debated, but a survival benefit is suggested. Mineralocorticoids and chronic kidney disease have been linked to cardiovascular fibrosis. Therefore, we hypothesized that spironolactone would affect vascular stiffness, cardia...

Descripción completa

Detalles Bibliográficos
Autores principales: Eklund, Michael, Hellberg, Olof, Furuland, Hans, Cao, Yang, Wall, Kent, Nilsson, Erik
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Open Academia 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9169545/
https://www.ncbi.nlm.nih.gov/pubmed/35722182
http://dx.doi.org/10.48101/ujms.v127.8594

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9169545/
https://www.ncbi.nlm.nih.gov/pubmed/35722182
http://dx.doi.org/10.48101/ujms.v127.8594

Ejemplares similares